Akebia Therapeutics | AKBA - Credores Comerciais





Credores Comerciais Alterar Data
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Ardelyx USD 28.2M 8.96M 2026-03
Astellas Pharma JPY 199.75B 17.8B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Bayer EUR 6.59B 496M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Celltrion KRW 78.68B 25.51B 2025-12
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Fresenius Medical Care EUR 890.43M 54.88M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
J&J USD 10.46B 1.53B 2026-03
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Moderna USD 161M 156M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 186K 23K 2025-06
Pharma Mar EUR 43.83M 10.51M 2026-03
Prothena USD 4.3M 1.58M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Qiagen NV USD 72.66M 2.11M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Sartorius EUR 345.3M 2.2M 2026-03
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03